Most COVID-19 vaccines and diagnostic kits for immunological testing target the SARS-CoV-2 spike (S) protein, particularly the receptor-binding domain (RBD), which is the viral component that directly interacts with target cells and stimulates virion internalization [1,2]. The gene discussed is PROS1; the disease is COVID-19.